Gambia vs Kazakhstan: Previously treated cases tested for RR-/MDR-TB
Gambia
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Gambia rank
1st
Kazakhstan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Gambia
- Kazakhstan
How they compare
Gambia currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 2 times across 16 shared years of data; in 2006 it was Kazakhstan ahead.
Gambia ranks 1st and Kazakhstan ranks 1st of 180 countries.
Across the 3 decades both report, Gambia averaged higher in 1 and Kazakhstan in 2.
Head to head by decade
| Decade | Gambia | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.8% | 50.2% | 2.5% | Gambia |
| 2010s | 53.6% | 93.3% | 39.7% | Kazakhstan |
| 2020s | 89.4% | 100.0% | 10.6% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Gambia or Kazakhstan?
- Gambia, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Gambia and Kazakhstan?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Kazakhstan?
- 16 years are reported by both, from 2006 to 2024.
- How do Gambia and Kazakhstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Gambia ranks 1st and Kazakhstan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.